Notably, conventional western blot analysis fails to identify heterogeneous Bax expression among cell subpopulations under cisplatin stimulation, while the ieSCI-chip provides accurate information for determining whether tumor cells show evidence of resistance to chemotherapeutic drugs. This evidence concerns the gene BAX and neoplasm.